3
Action plans
Effective policy and practice change at national level will only be the result of a unifiedevidence-based approach to the management of MSDs, delegates heard. Specifically,national MSD action plans must:
•
Make MSDs a national public health priority, along with other serious chronicconditions
•
Allocate adequate funding for early intervention and treatment of MSDs
•
Establish 'staying in work' as a valid clinical measure of successful management ofMSDs
•
Advocate including work productivity (i.e., societal costs) in health economic/healthtechnology assessments
Conference floor: Practical steps – Ireland and Spain show the way
Practical steps and solutions towards making MSDs a health and work priority at the nationaland EU levels were discussed by keynote speaker Professor Oliver FitzGerald, NationalQCCD Programme Lead for Rheumatology, Ireland. An important message from ProfessorFitzGerald’s talk was the importance of engaging the medical profession in attempts toimprove work retention.
Figure 2
. Dame Carol Black chairs the morning’s panel discussion
“We are encouraging our colleagues to think beyond physical symptoms, to encourage earlyintervention both for musculoskeletal pain and also for other conditions like inflammatoryarthritis, to promote self management, to support managers with job design interventions, tofocus on capacity and not incapacity, and we are emphasising to rheumatologist theimportance of communicating with all of the other stakeholders, including patients,employees, GPs, physiotherapists, employers and policymakers, the overall message thatwork is good for you and that we should try to maintain our patients in the workplace asmuch as possible,” he said.Professor Juan A. Jover, Rheumatology Service, Hospital Clínico San Carlos, Madrid, Spainshowed that national goals can be turned into clinical reality if bottlenecks preventing people
Add a Comment